MIAMI, FL, June 10, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on…
Preclinical data highlights the therapeutic potential of Ashvattha’s novel CSF1R tyrosine kinase inhibitor (CSF1R dendranib) for multiple sclerosis (MS) based…
New role highlights RenovoRx’s commitment to explore and execute on clinical and commercial business development opportunities with its therapeutic technologyLOS…
-- New integration to streamline access for health systems and improve provider and patient journeys using Epic for electronic connections…
DENVER, June 10, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (SeaStar Medical) announces that three new members…
Launching the Mature Workers Programme LONDON, June 10, 2024 /PRNewswire/ -- Halixia, a purpose-based UK fintech dedicated to enhancing the…
New program will address exponential growth in attacks threatening access to care for Americans and bring enterprise-quality cybersecurity to the…
Global early-stage fund to catalyze development of the next generation of treatments Backers include the leading spinal cord injury foundations…
DUBAI, UAE, June 10, 2024 /PRNewswire/ -- XRP Healthcare, a trailblazer in the healthcare sector, is proud to announce the…
Vancouver, British Columbia--(Newsfile Corp. - June 10, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC), ("Defence" or…